Loss of Exclusivity Tracking demo
One live horizon of every product and market to its generic or biosimilar entry date, each date cited to the patent, exclusivity or settlement that sets it, with the legal clocks counting down beside it. 1:12
What the demo shows
An IP intelligence solution for IP leaders that maps each product's patents and entry dates.
Six agents keep a cited map of every patent (compound, formulation, method of use, process), term extension, pediatric extension, regulatory exclusivity, challenger and settlement term for each product and market. They watch patent offices, courts and FDA lists, recompute the expected entry date and its downside case within hours, and count the statutory clocks down beside the horizon. The Chief Patent Counsel decides the date of record; Finance receives only decided dates.
Transcript
- Loss of Exclusivity Tracking maps each product patents to its generic entry date for IP leaders.
- Those dates move on court decisions that spreadsheets miss for weeks.
- Each lane runs from today to generic entry.
- Beside it, the legal clocks count down live.
- On October 2nd, the Patent Board instituted a review of Corventa's formulation patent.
- The Corventa US lane shortens and the downside appears.
- 2033, $7.6 billion at risk.
- Agents read the order, re-read six settlements, and re-computed the date, cited.
- The date holds. Omar raises the downside to 40% and sends it to finance.
- A cited generic entry date per market within hours of any change.
- Built on Botminds.
- Agents, data, screens, and governance on one platform.
Transcribed from the film’s narration. Captions are on the player.